This represents a typical mechanism of adaptive resistance, where the immune system recognizes cancer, but protects itself by adapting to the immune attack mediated by infiltrating T cells through the production of immunosuppressive factors, such as PD-L1, TGF-ß, and IDO1 (13). Here, IDO1 is linked to cancer.